Download Word file - SLT by Ellex

[ADD CLINIC LOGO]
Contact:
[PR Contact]
[Clinic]
[Phone]
[Email]
[CLINIC NAME] Introduces Non-Invasive Laser Therapy for
Glaucoma: SLT
[City, Date]  On (add date) the [CLINIC NAME] announced the introduction of SLT, an
innovative, non-invasive laser treatment for glaucoma. This quick and simple procedure may be
an option for most patients, but is especially suited for patients who cannot tolerate or are
unable to self-administer glaucoma medications.
Highly effective, SLT is used as primary treatment for early stages of open angle glaucoma, and
can also be used in combination with drug therapy or as an alternative therapy when drugs fail.
It is also a flexible treatment option, given that it can be repeated, if necessary, depending on
the individual patient’s response.
Glaucoma is the leading cause of blindness in North America and Europe and the second
leading cause worldwide. It is most often associated with an increase of pressure inside the eye,
which, over time, can cause damage to some of the sensitive structures that receive and
transmit images in the back of the eye, ultimately resulting in irreversible loss of vision.
SLT uses the principle of photoregeneration: the SLT laser applies short pulses of low-energy
light to prompt a photo-regenerative response in the trabecular meshwork of the eye, which
leads to lowered intraocular pressure. Gentle, non-invasive and repeatable, SLT promotes
cellular regeneration without the burn and tissue scarring associated with other conventional
laser procedures for glaucoma.
Good candidates for SLT include primary-open angle, normal tension, pseudoexfoliation, or
pigmentary glaucoma patients who:

Wish to use SLT as a primary glaucoma treatment

Find it challenging to take glaucoma medications due to time or financial constraints,
non-compliance and quality-of-life issues

Are currently undergoing drug therapy and need to further reduce IOP without adding
drugs

Wish to keep the number of drugs to a minimum

Do not tolerate drugs due to their adverse effects

Experience loss of the pressure-lowering effects of drug therapy

Have had Argon Laser Trabeculoplasty that has failed
“We are excited to be among the first clinics in (ADD COUNTRY) to offer this gentle, noninvasive treatment option to our patients” says Dr. [DOCTOR’S NAME], Medical Director at
[CLINIC NAME]. Since its original introduction we have been following the clinical studies and
outcomes related to SLT closely and we view it as a safe and effective treatment for open-angle
glaucoma – including primary therapy, adjunct therapy with drugs, and alternative therapy when
drugs fail. SLT is especially suited to patients that have compliance issues or do not tolerate
the medication“.
About [CLINIC NAME]
[ADD BOILER PLATE, 50 WORD SUMMARY ABOUT THE CLINIC]
-more-